• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION SYNVISC; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION SYNVISC; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Nausea (1970)
Event Date 02/25/1998
Event Type  Death  
Event Description
Patient received first of three injectable treatment with synvisc on (b)(6).Second injection was given on (b)(6) 1998.The patient received the injection at approximately 1:45 pm.The patient returned to the nursing home and reported nausea at 4 pm (not an unusual complaint according to reporter).The patient was checked at 8:30 pm and complained of nausea.The patient was found dead at 10:10 pm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
GENZYME CORPORATION
MDR Report Key10828834
MDR Text Key216193016
Report NumberMW5097772
Device Sequence Number2
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 04/16/1998
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received11/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age87 YR
-
-